Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea (LOFT-HF)

NCT03745898 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT03745898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03745898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea (LOFT-HF)
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 3
Overall status
Terminated
Start date
April 15, 2019
Completion date
June 17, 2022
Enrollment
98 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

central sleep apnea, heart failure